The synthesis and biological evaluation of 1-C-alkyl-l- arabinoiminofuranoses, a novel class of α-glucosidase inhibitors

Yoshihiro Natori, Tatsushi Imahori, Keiichi Murakami, Yuichi Yoshimura, Shinpei Nakagawa, Atsushi Kato, Isao Adachi, Hiroki Takahata*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Abstract

The asymmetric synthesis of 1-C-alkyl-l-arabinoiminofuranoses 1 was achieved by asymmetric allylic alkylation (AAA), ring closing metathesis (RCM), and Negishi cross coupling as key reactions. Some of the prepared compounds showed potent inhibitory activities towards intestinal maltase, with IC 50 values comparable to those of commercial drugs such as acarbose, voglibose, and miglitol, which are used in the treatment of type 2 diabetes. Among them, the inhibitory activity (IC 50 = 0.032 μM) towards intestinal sucrase of 1c was quite strong compared to the above commercial drugs.

Original languageEnglish
Pages (from-to)738-741
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume21
Issue number2
DOIs
StatePublished - 2011/01/15

Keywords

  • 1-C-Alkyl-l-arabinoiminofuranose
  • Asymmetric allylic alkylation
  • Negishi cross coupling
  • Type 2 diabetes
  • α-Glucosidase inhibitor

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'The synthesis and biological evaluation of 1-C-alkyl-l- arabinoiminofuranoses, a novel class of α-glucosidase inhibitors'. Together they form a unique fingerprint.

Cite this